Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

EQL Pharma: Fårö Capital divests further EQL shares to enable increased institutional ownership and create more liquidity in the share

EQL Pharma

As EQL grows larger, and ahead of a future NASDAQ listing, it is desirable to broaden the ownership base and enable more institutions to become owners of EQL. In the long term, this contributes to more liquid trading in the share and a wider interest in the company.

Fårö has today sold 1 million shares to an institutional buyer base and after the sale owns 7,427 million shares corresponding to 25,5 % of the shares and capital.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team